Lly stock forecast technical LLY stock forecast patterns

Technical LLY stock forecast patterns show a cup-and-handle formation forming on the weekly chart. Breakout above $830 could align with biotech sector ETF inflows, adding further upside potential. for NVO. (ii) Novo is under cost and operational stress with the new mangament team. After almost doubling its workforce in the previous five years of surging GLP-1 demand, the company is freezing hiring and considering to do some As for the "research renaissance" that I maintain is occurring, I shall first highlight the GLP-1 class of medications. These are the most transformative drug class of my (lengthy) career, not because of "obesity per se," but because of the multi-metabolic disease efficacy. The benefits are in Type 2 diabetes, cardiology, hepatology, nephrology, sleep apnea and knee osteoarthritis. Furthermore, there should soon be data on possible benefits in CNS disease and oncology. LLY stock forecast sentiment improved after strategic acquisitions expanded oncology capabilities. With strong balance sheet metrics—debt-to-equity ratio at 1.2—the company retains room for further M&A-driven growth.